HRs and 95% CI for the association between each pulmonary condition and diabetes status among KPNC survey responders
| . | Model 1* . | Model 2† . |
|---|---|---|
| Asthma‡ | 2.21 (1.72–2.85) | 1.08 (1.03–1.12) |
| COPD‡ | 1.57 (1.40–1.77) | 1.22 (1.15–1.28) |
| Fibrosis‡ | 1.64 (1.23–2.18) | 1.54 (1.31–1.81) |
| Pneumonia‡ | 2.47 (2.32–2.62) | 1.92 (1.84–1.99) |
| Lung cancer§ | 1.05 (0.94–1.17) | 1.10 (0.96–1.26) |
| . | Model 1* . | Model 2† . |
|---|---|---|
| Asthma‡ | 2.21 (1.72–2.85) | 1.08 (1.03–1.12) |
| COPD‡ | 1.57 (1.40–1.77) | 1.22 (1.15–1.28) |
| Fibrosis‡ | 1.64 (1.23–2.18) | 1.54 (1.31–1.81) |
| Pneumonia‡ | 2.47 (2.32–2.62) | 1.92 (1.84–1.99) |
| Lung cancer§ | 1.05 (0.94–1.17) | 1.10 (0.96–1.26) |
*Adjusted for age, sex, and race/ethnicity.
†Adjusted for age, sex, race/ethnicity, smoking, BMI, education, alcohol consumption, and number of outpatient visits.
‡Primary discharge diagnosis or underlying cause of death in the Kaiser Permanente databases.
§Identified through the KPNC Cancer Registry.